{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:03:49Z","timestamp":1791558229321,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.4158\/ep161717.ra","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T11:32:12Z","timestamp":1490268732000},"page":"680-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["An Individualized Approach to The Evaluation and Management of Primary Aldosteronism"],"prefix":"10.1016","volume":"23","author":[{"given":"Anand","family":"Vaidya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Malchoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP161717.RA_bb0010","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1055\/s-0035-1565182","article-title":"Primary Aldosteronism: New Answers, New Questions","volume":"47","author":"Funder","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.4158\/EP161717.RA_bb0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.114.03231","article-title":"Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"10.4158\/EP161717.RA_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.4158\/EP161717.RA_bb0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.111.00662","article-title":"Abnormal aldosterone physiology and cardiometabolic risk factors","volume":"61","author":"Vaidya","year":"2013","journal-title":"Hypertension"},{"key":"10.4158\/EP161717.RA_bb0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.4158\/EP161717.RA_bb0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP161717.RA_bb0045","first-page":"3570","article-title":"Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism","volume":"82","author":"Litchfield","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/01.HYP.28.6.927","article-title":"Inherited forms of mineralocorticoid hypertension","volume":"28","author":"White","year":"1996","journal-title":"Hypertension"},{"key":"10.4158\/EP161717.RA_bb0055","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0060","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1161\/CIR.0000000000000051","article-title":"Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning Group","volume":"129","author":"Antman","year":"2014","journal-title":"Circulation"},{"key":"10.4158\/EP161717.RA_bb0065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","article-title":"Effects of eplerenone versus losartan in patients with low-renin hypertension","volume":"150","author":"Weinberger","year":"2005","journal-title":"Am Heart J"},{"key":"10.4158\/EP161717.RA_bb0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"key":"10.4158\/EP161717.RA_bb0075","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.4158\/EP161717.RA_bb0080","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.4158\/EP161717.RA_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161717.RA_bb0090","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.4158\/EP161717.RA_bb0095","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/jc.2012-3353","article-title":"Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension","volume":"98","author":"Markou","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0100","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of Renin-Independent Aldosteronism in Normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.4158\/EP161717.RA_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2016.01.003","article-title":"Local Control of Aldosterone Production and Primary Aldosteronism","volume":"27","author":"Lalli","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0110","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0115","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP161717.RA_bb0120","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"Kupers","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0125","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1210\/jc.2013-3789","article-title":"Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism","volume":"99","author":"Riester","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0130","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","article-title":"Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma","volume":"85","author":"Phillips","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","article-title":"Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases","volume":"86","author":"Rossi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.4158\/EP161717.RA_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP161717.RA_bb0150","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0155","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"10.4158\/EP161717.RA_bb0160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiology.184.3.1509049","article-title":"Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT","volume":"184","author":"Doppman","year":"1992","journal-title":"Radiology"},{"key":"10.4158\/EP161717.RA_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","article-title":"Hyperaldosteronism: sampling the adrenal veins","volume":"198","author":"Doppman","year":"1996","journal-title":"Radiology"},{"key":"10.4158\/EP161717.RA_bb0170","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and Post-ACTH Aldosterone and Its Ratios Are Useful During Adrenal Vein Sampling in Primary Aldosteronism","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0175","doi-asserted-by":"crossref","unstructured":"ViolariEG, MalchoffC, AriciM, et al. The value of adrenal vein sampling pre-ACTH stimulation for the diagnosis of surgically remediable hyperaldosteronism. In: Program of the annual meeting of the Society of Interventional Radiology, April 2\u20137, 2016; Vancouver, British Columbia. Oral presentation.","DOI":"10.1016\/j.jvir.2015.12.243"},{"key":"10.4158\/EP161717.RA_bb0180","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cen.13110","article-title":"Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?","volume":"85","author":"Wolley","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161717.RA_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MED.0b013e32834693bf","article-title":"Minimally invasive adrenal surgery: an update","volume":"18","author":"Nehs","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.4158\/EP161717.RA_bb0190","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2016152277","article-title":"Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate","volume":"281","author":"Liu","year":"2016","journal-title":"Radiology"},{"key":"10.4158\/EP161717.RA_bb0195","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2016.03.042","article-title":"Clinical Outcomes following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma: Comparison with Adrenalectomy","volume":"27","author":"Sarwar","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.4158\/EP161717.RA_bb0200","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0205","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2012-2234","article-title":"Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy","volume":"97","author":"Fischer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161717.RA_bb0210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1681\/ASN.2014111137","article-title":"Activation of the Endogenous Renin-Angiotensin-Aldosterone System or Aldosterone Administration Increases Urinary Exosomal Sodium Channel Excretion","volume":"27","author":"Qi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP161717.RA_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1681\/ASN.2015111221","article-title":"In Primary Aldosteronism, Mineralocorticoids Influence Exosomal Sodium-Chloride Cotransporter Abundance","volume":"28","author":"Wolley","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP161717.RA_bb0220","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:03:09Z","timestamp":1761516189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1530891X20358079"],"URL":"https:\/\/doi.org\/10.4158\/ep161717.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Individualized Approach to The Evaluation and Management of Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161717.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}